Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
biloxiblues's Profile
Displaying 1-50 of 667 result(s).
CYDY CytoDyn Inc
07/25/2025 3:46:34 PM
https://www.reddit.com/r/Livimmune (1)
CYDY CytoDyn Inc
07/23/2025 8:29:23 PM
We will be fine! (2)
CYDY CytoDyn Inc
07/22/2025 7:37:02 PM
I am not a Doctor, but this is Gem (4)
CYDY CytoDyn Inc
07/21/2025 3:10:55 PM
This is an interesting read on Cyto (4)
CYDY CytoDyn Inc
07/19/2025 5:25:33 PM
Does leronlimab have orphan drug st (11)
CYDY CytoDyn Inc
07/18/2025 3:09:24 PM
You can tell we are at the end when (19)
CYDY CytoDyn Inc
06/27/2025 2:08:09 PM
Then, explain who is going to repor (7)
CYDY CytoDyn Inc
06/27/2025 1:52:50 PM
There are approximately 620,000 reg (5)
CYDY CytoDyn Inc
06/27/2025 9:18:55 AM
Exactly My69z It appears that this (2)
CYDY CytoDyn Inc
06/21/2025 2:50:09 PM
The FDA recently announced a new pi
CYDY CytoDyn Inc
06/20/2025 9:06:48 AM
The article is titled "The Role an (7)
CYDY CytoDyn Inc
06/17/2025 4:21:56 PM
Thoughts from ChatGpt, This FDA ann (3)
CYDY CytoDyn Inc
06/17/2025 9:32:19 AM
Yes, and we remain unchanged.35 cen
CYDY CytoDyn Inc
06/17/2025 9:18:53 AM
Just curious, has anyone followed R (2)
CYDY CytoDyn Inc
06/10/2025 7:26:25 PM
FDA Turns to AI for a Shot in the A (2)
CYDY CytoDyn Inc
06/04/2025 9:34:21 AM
Interesting hoops, so I put a quest (8)
CYDY CytoDyn Inc
06/02/2025 9:12:45 AM
hoops I thought I would ask ChatGpt (15)
CYDY CytoDyn Inc
05/28/2025 7:24:22 AM
OHM20, how about this one! On Inves (9)
CYDY CytoDyn Inc
05/27/2025 3:59:40 PM
I enjoy www.elicit.com for AI on Le (4)
CYDY CytoDyn Inc
05/25/2025 4:14:39 PM
No — The FDA did not say the last (9)
CYDY CytoDyn Inc
05/25/2025 8:05:47 AM
Summary of Leronlimab’s Path and (9)
CYDY CytoDyn Inc
05/25/2025 8:02:37 AM
This should go to every media outle (15)
CYDY CytoDyn Inc
05/23/2025 9:56:02 AM
Can you give us an idea of what Pau (2)
CYDY CytoDyn Inc
05/21/2025 7:31:37 PM
A few years back, I spoke with a se (16)
CYDY CytoDyn Inc
05/21/2025 7:22:14 PM
Praying for him and his family. I a (3)
CYDY CytoDyn Inc
05/21/2025 2:26:30 PM
It’s like that story of the guy w (6)
CYDY CytoDyn Inc
05/21/2025 9:42:54 AM
Hi Ritz Some are rushing to jump in (7)
CYDY CytoDyn Inc
05/20/2025 4:08:18 PM
When the word finally gets out, we (4)
CYDY CytoDyn Inc
05/18/2025 5:38:49 PM
I am not a doctor either, Sean007, (11)
CYDY CytoDyn Inc
05/18/2025 10:14:00 AM
You're analyzing the survival data (21)
CYDY CytoDyn Inc
05/18/2025 10:09:41 AM
Excellent question — and highly r (12)
CYDY CytoDyn Inc
05/17/2025 1:04:31 PM
The OPTIMIZE trial tested Leronlima (8)
CYDY CytoDyn Inc
05/17/2025 12:22:59 PM
Leronlimab Treatment for Multidrug- (4)
CYDY CytoDyn Inc
05/17/2025 7:36:32 AM
Great question, Ramjet, so I asked (12)
CYDY CytoDyn Inc
05/15/2025 7:35:56 PM
Please read this, as I know people (3)
CYDY CytoDyn Inc
05/15/2025 12:56:00 PM
This could explain a lot of the sel (21)
CYDY CytoDyn Inc
05/15/2025 9:12:31 AM
Ken, good catch. Cytodyn PR person (9)
CYDY CytoDyn Inc
05/15/2025 8:57:18 AM
This ESMO 2025 poster from CytoDyn (12)
CYDY CytoDyn Inc
05/14/2025 4:20:37 PM
Yes, the technicals look amazing!
CYDY CytoDyn Inc
05/14/2025 1:42:18 PM
www.barchart.com` On the left, hit (3)
CYDY CytoDyn Inc
05/14/2025 7:45:16 AM
3rd Resistance Point 0.4969 2nd Res (4)
CYDY CytoDyn Inc
05/14/2025 7:31:49 AM
This is probably the best question (15)
CYDY CytoDyn Inc
05/13/2025 10:31:49 AM
I asked my buddy ChatGPT after toda (2)
CYDY CytoDyn Inc
05/13/2025 9:07:42 AM
What They Found: CytoDyn reviewed d (20)
CYDY CytoDyn Inc
05/13/2025 6:28:51 AM
Katangolo An excellent book was wri (12)
CYDY CytoDyn Inc
05/10/2025 4:28:07 PM
Sean007 I am just curious, when do (1)
CYDY CytoDyn Inc
05/09/2025 2:44:58 PM
This is the stock today that will b (4)
CYDY CytoDyn Inc
05/08/2025 9:03:07 AM
Hoops, you are so right! (1)
CYDY CytoDyn Inc
05/08/2025 9:02:10 AM
Thank you, Misiu. Some people seem (11)
CYDY CytoDyn Inc
05/08/2025 6:51:22 AM
Nader is not in jail Ohm20 did the (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Understanding the Growth of Investment in Mosaic Over Time
  • Legal Insight: Examining Recent Mergers of CEPO, EFIN, SQCF, TLGYF
  • Investors Invited to Join Fiserv, Inc. Securities Action
  • Brigham Young University Faces Investigation Over Data Breach
  • Univest Securities Completes $4.2 Million Offering for GSIW
  • Skechers U.S.A. Faces Class Action: Investor Insights and More
  • Revolutionizing DeFi: aPriori's Insights on Latency Challenges
  • Understanding the Implications of Recent Mergers for Shareholders
  • Legal Inquiry: Mergers and Acquisitions Affecting Shareholders
  • LivePerson Announces Recent Equity Incentive Awards Details
  • Exciting New Travel Deals Released by Travelzoo for Members
  • Kinross Gold Corporation Completes Sale of White Gold Shares
  • Investigation Launched for Data Breach Impacting NASCAR Fans
  • Easterly ROCMuni Fund Faces Legal Scrutiny: Investor Alert
  • Urgent Notice for XPLR Infrastructure Investors: Act Now
  • Discover Magnite's Impressive Growth Over the Past 5 Years
  • PharmAla Biotech Expands Operations with Strong Q3 Results
  • Discover the Innovative GREY'S ANATOMY™ EMERGE Collection Today
  • Nabors Industries Welcomes David Tudor to the Board of Directors
  • Edelson Lechtzin LLP Investigates Premier Health Data Breach
  • U.S. Strengthens Trade Laws Against Unfair Lumber Practices
  • Berklee College of Music Honors Oliver Charles with Scholarship
  • ECN Capital Plans Conference Call for Q2-2025 Financials
  • Barnes & Noble Education Faces Legal Inquiry into Stock Practices
  • Eshallgo Inc. Faces Nasdaq Compliance Challenge Ahead
  • Class Action Alert for Rocket Pharmaceuticals Investors
  • Fairfax Financial Hosts Conference Call for Second Quarter Insights
  • ECN Capital Plans to Discuss Second Quarter 2025 Results
  • PharmAla Reports Impressive Growth and Key Milestones Achieved
  • Legal Action on Behalf of XPLR Infrastructure Unit Holders
  • Fairfax Financial Schedules Conference Call for Earnings Review
  • Teamsters Local 79 Celebrate New Contract with Southern Glazer's
  • Understanding CRH Inc.'s Strong Performance and P/E Ratio
  • Tesla Stock Surges Following Important Trading Indicators
  • What Five Years of Ownership Could Mean for TRGP Investors
  • Fannie Mae to Release Financial Results and Host Webcast Event
  • Birks Group Inc. Reveals Fiscal Year 2025 Insights and Future Plans
  • Edelson Lechtzin LLP Investigates Data Breach at McKenzie Hospital
  • Fannie Mae Prepares for Key Financial Results Announcement
  • Teamsters Celebrate Landmark Contract at Southern Glazer's
  • Unlocking New Opportunities: ThreeD Capital's Bold Financing Plans
  • Understanding the Sarepta Therapeutics Class Action Lawsuit
  • Fortrea Holdings Inc. Faces Class Action Lawsuit Update
  • Reckitt Benckiser Group Investors: Class Action Details Explained
  • Petco Health and Wellness Faces Class Action Lawsuit: Details Inside
  • Alto Neuroscience Investors Alerted to Class Action Opportunities
  • Investors Alert: Class Action Lawsuit Against 3D Systems Corp
  • Levi & Korsinsky Informs PepGen Inc. Investors on Lawsuit
  • Biohaven Ltd. Class Action: Important Insights for Investors
  • Hims & Hers Health Faces Legal Action Over Securities Claims
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site